Coherent Corp. (COHR) Stock Forecast Oct. 16, 2026
Analysis updated on Oct. 16, 2026 (UTC) · Alpha · vs marketSwitch to Total · NYSE
Coherent Corp. (COHR) stock forecast summary
On Oct. 16, 2026, COHR is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
Coherent Corp. is a large-cap company with a market capitalization of $45.61B. It ranks number 2 by market capitalization among the 7 Optical Instruments & Lenses issuers in our coverage with a current forecast.
For COHR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 29.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, COHR included.
Follow COHR freeCOHR price chart and AI forecast
How COHR ranks among 5172 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Coherent Corp. (COHR) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Optical Instruments & Lenses peers listed below that report each metric.
Valuation & Market
| Metric | COHR | Rank |
|---|---|---|
| Market Cap | $45.61B | 2/7 |
| P/E Ratio | 56.53x | 1/5 |
| P/B Ratio | 8.75x | 3/7 |
| Dividend Yield | 0.03% | – |
| EPS | $4.12 | – |
| Book Value/Share | $26.60 | – |
| Revenue/Share | $36.35 | – |
| FCF/Share | $-5.23 | – |
Profitability & Margins
| Metric | COHR | Rank |
|---|---|---|
| Gross Margin | 37.5% | 4/5 |
| EBT Margin | 16.1% | 4/7 |
| Tax Rate | 7.2% | – |
Financial Health
| Metric | COHR | Rank |
|---|---|---|
| Current Ratio | 2.43x | 6/6 |
| Quick Ratio | 1.52x | 6/6 |
| D/E Ratio | 1.26x | 2/7 |
| Interest Coverage | 0.7x | 5/6 |
| Working Capital | $4.07B | 1/6 |
Cash Flow
| Metric | COHR | Rank |
|---|---|---|
| Operating Cash Flow | $80M | 4/7 |
| Free Cash Flow | -$1.02B | – |
| Capital Spending | -$1.10B | – |
| OCF Growth YoY | -87.5% | 5/5 |
| FCF Growth YoY | -630.9% | – |
| FCF/Sales | -14.4% | – |
| CapEx/Sales | 15.5% | – |
Operational Efficiency
| Metric | COHR | Rank |
|---|---|---|
| Receivables Turnover | 5.3x | – |
| Inventory Turnover | 1.7x | 3/5 |
| Fixed Assets Turnover | 2.4x | – |
| Days Sales Outstanding | 69 days | – |
| Days Inventory | 212 days | 3/5 |
| Payables Period | 156 days | 1/5 |
| Cash Conversion Cycle | 124 days | – |
Income Statement
| Metric | COHR | Rank |
|---|---|---|
| Total Revenue | $7.12B | – |
| R&D Expense | $723M | – |
| SG&A Expense | $1.04B | 2/6 |
| Cost of Goods Sold | $4.45B | 2/6 |
Dividend & Shareholder Information
| Metric | COHR | Rank |
|---|---|---|
| Dividends Per Share | $0.06 | – |
| Payout Ratio | 1.5% | – |
| Shares Outstanding | 196M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $6.93B | 47.8% of assets |
| Cash & Short-term Investments | $1.16B | 8.0% of assets |
| Accounts Receivable | $1.34B | 9.3% of assets |
| Inventory | $2.58B | 17.8% of assets |
| Total Liabilities | $6.54B | 45.2% of assets |
| Short-term Debt | $949M | 6.5% of assets |
COHR quarterly financials and insider trading
Coherent Corp. (COHR) industry peers
Companies classified under the same SEC industry code as Coherent Corp. (Optical Instruments & Lenses): 7 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up freeWhere COHR sits on the market map
Coherent Corp. (COHR) stock news
Loading...
Coherent Corp. (COHR) stock forecast FAQ
What is the Coherent Corp. (COHR) stock forecast?
On Oct. 16, 2026, COHR is rated Neutral: its 90-day Alpha forecast sits in the middle 30% of the 5172 stocks scored that day.
How accurate are Coherent Corp. stock predictions?
For COHR, the Spearman rank correlation between our 90-day forecasts and the returns that followed is 44.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is 29.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Coherent Corp. forecasts updated?
Coherent Corp. forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 16, 2026.
Which companies are Coherent Corp.'s industry peers?
7 issuers in our coverage, COHR included, share the SEC industry code Optical Instruments & Lenses. The largest are: Kla Corp (KLAC), Nova Ltd. (NVMI), Camtek Ltd (CAMT), Syntec Optics Holdings, Inc. (OPTX), Optex Systems Holdings Inc (OPXS), Multisensor Ai Holdings, Inc. (MSAI).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.